DOYLE THOMAS JAMES

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DOYLE THOMAS JAMES's trades of Kura Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
326.99
Quantity 56,300
Value US$4,022,684
Transaction date
Sale
Price
490.11
Quantity 78,388 +16.1%
Value US$4,305,149
Transaction date
Sale
Price
373.54
Quantity 20,164 -33.6%
Value US$3,952,664
Transaction date
Sale
Price
8.46
Quantity 695 -0.5%
Value US$5,880
Transaction date
Sale
Price
8.46
Quantity 1,114 -0.7%
Value US$9,425
Transaction date
Sale
Price
8.46
Quantity 2,226 -1.5%
Value US$18,834
Transaction date
Proposed sale
Price
10.68
Quantity 4,539
Value US$48,477
Transaction date
Sale
Price
11.18
Quantity 4,539 -3.4%
Value US$50,732
Transaction date
Proposed sale
Price
9.05
Quantity 4,541
Value US$41,096
Transaction date
Sale
Price
8.94
Quantity 4,541 -4.0%
Value US$40,607
Transaction date
Proposed sale
Price
7.77
Quantity 4,949
Value US$38,454
Transaction date
Sale
Price
7.87
Quantity 1,122 -1.3%
Value US$8,832
Transaction date
Sale
Price
7.87
Quantity 699 -0.8%
Value US$5,502
Transaction date
Sale
Price
7.87
Quantity 887 -1.0%
Value US$6,982
Transaction date
Sale
Price
7.87
Quantity 2,241 -2.4%
Value US$17,641
Transaction date
Sale
Price
17.80
Quantity 963 -2.0%
Value US$17,142
Transaction date
Sale
Price
17.80
Quantity 761 -1.5%
Value US$13,546
Transaction date
Sale
Price
17.80
Quantity 594 -1.2%
Value US$10,573
Transaction date
Sale
Price
13.89
Quantity 866 -4.9%
Value US$12,029
Transaction date
Planned sale
Price
13.89
Quantity 682 -3.7%
Value US$9,473
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-27 2026-01-27
PrS Proposed sale
56,300
326.99
US$4,022,684 		56,300 326.99 US$4,022,684
2026-01-27 2026-01-27
S Sale
78,388 +16.1%
490.11
US$4,305,149 		78,388 +16.1% 490.11 US$4,305,149
2026-01-27 2026-01-27
S Sale
20,164 -33.6%
373.54
US$3,952,664 		20,164 -33.6% 373.54 US$3,952,664
2026-01-27 2026-01-27
S Sale
695 -0.5%
8.46
US$5,880 		695 -0.5% 8.46 US$5,880
2026-01-27 2026-01-27
S Sale
1,114 -0.7%
8.46
US$9,425 		1,114 -0.7% 8.46 US$9,425
2026-01-27 2026-01-27
S Sale
2,226 -1.5%
8.46
US$18,834 		2,226 -1.5% 8.46 US$18,834
2025-11-14 2025-11-14
PrS Proposed sale
4,539
10.68
US$48,477 		4,539 10.68 US$48,477
2025-11-14 2025-11-14
S Sale
4,539 -3.4%
11.18
US$50,732 		4,539 -3.4% 11.18 US$50,732
2025-09-29 2025-09-29
PrS Proposed sale
4,541
9.05
US$41,096 		4,541 9.05 US$41,096
2025-09-29 2025-09-29
S Sale
4,541 -4.0%
8.94
US$40,607 		4,541 -4.0% 8.94 US$40,607
2025-01-28 2025-01-28
PrS Proposed sale
4,949
7.77
US$38,454 		4,949 7.77 US$38,454
2025-01-28 2025-01-28
S Sale
1,122 -1.3%
7.87
US$8,832 		1,122 -1.3% 7.87 US$8,832
2025-01-28 2025-01-28
S Sale
699 -0.8%
7.87
US$5,502 		699 -0.8% 7.87 US$5,502
2025-01-28 2025-01-28
S Sale
887 -1.0%
7.87
US$6,982 		887 -1.0% 7.87 US$6,982
2025-01-28 2025-01-28
S Sale
2,241 -2.4%
7.87
US$17,641 		2,241 -2.4% 7.87 US$17,641
2024-01-31 2024-01-29
S Sale
963 -2.0%
17.80
US$17,142 		963 -2.0% 17.80 US$17,142
2024-01-31 2024-01-29
S Sale
761 -1.5%
17.80
US$13,546 		761 -1.5% 17.80 US$13,546
2024-01-31 2024-01-29
S Sale
594 -1.2%
17.80
US$10,573 		594 -1.2% 17.80 US$10,573
2023-01-31 2023-01-27
S Sale
866 -4.9%
13.89
US$12,029 		866 -4.9% 13.89 US$12,029
2023-01-31 2023-01-27
PlS Planned sale
682 -3.7%
13.89
US$9,473 		682 -3.7% 13.89 US$9,473